Musculoskeletal Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals aged between 18 and 70 years, of both genders with musculoskeletal pain, myalgia or arthralgia, persisting after four weeks of Covid-19 infection. Individuals with pain rating equal to or greater than 3 on the Visual Analogue Scale. Individuals classified as grade 1, 2 and 3 on the modified Medical Research Council scale
Exclusion criteria
Exclusion criteria: Individuals with pain rating lower than 3 on the Visual Analogue Scale. Individuals with grades 4 and 5 on the modified Medical Research Council scale. Individuals with chronic pain complaint in the treatment region, prior to Covid-19. Individuals with epilepsy, fibromyalgia, cardiac alterations and decompensated diabetes. Recent surgeries in regions related to the treatment site with less than 3 months; Laser photosensitivity; Continuous use of analgesics, muscle relaxants or anti-inflammatory drugs in the 48 hours prior to the intervention. pregnant women. Individuals with neurological and cognitive dysfunctions, such as dementia, intellectual disability, communicative deficit or any other condition that makes it impossible to understand the study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the threshold of pain by pressure, using algometry as a method, with an analog algometer. Where we will measure pain intensity in kilogram-force before the first session, after the third session, and after four weeks of treatment. It is expected to find at least a 5% variation in pre- and post-intervention measurements between the intervention and placebo groups | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate quality using the The World Health Organization Quality of Life Questionnaire as a method, where we will calculate scores for the physical, psychological, social relations, and environment domains before the first session, after the third session, and after four weeks of treatment. It is expected to find at least a 5% variation in pre- and post-intervention measurements between the intervention and placebo groups ;Assess pain using the Multidimensional Pain Rating Scale as a method. Where we will evaluate the intensity of pain, which varies between 0 and 10, the location of pain by means of a body diagram, and the pain descriptors for language evaluation. The assessment will be done before the first session, after the third session, and after four weeks of treatment. It is expected to find a variation of at least 5% in pre- and post-intervention measurements between the intervention and placebo groups;Evaluation of the physical and functional performance of patients, using the 5-repetition Sit and Stand Up Chair Test as a method. We will measure the time it takes the individual to get up five times from a sitting position, as quickly as possible, before the first session, after the third session, and after four weeks of treatment. We expect to find at least a 5% variation in pre- and post-intervention measurements between the intervention and placebo groups | — |
Countries
Brazil
Contacts
Universidade Federal de Santa Catarina. Campus Araranguá